QA: Alimera Sciences INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001267602_2016_Alimera_Sciences_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest'}

Graph

Absolute values for 0001267602, Alimera Sciences INC

  xvar xval
0 AssetsCurrent 45,159,000
1 IntangibleAssetsNetIncludingGoodwill 22,549,000
2 PropertyPlantAndEquipmentNet 2,553,000
3 remainder_Assets 223,000
4 LiabilitiesCurrent 39,933,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,980,851
9 ResearchAndDevelopmentExpense 16,327,025
10 remainder_Expenses 38,526,773
11 remainder_Revenues 92,493,040
12 remainder_NetIncome 11,360,250
13 remainder_ComprehensiveNetIncome -333,156
  yvar yval
0 Assets 70,484,000
1 Liabilities 39,933,000
2 Expenses 69,834,649
3 Revenues 92,493,040
4 StockholdersEquity 30,551,000
5 NetIncome 34,018,641
6 ComprehensiveNetIncome 33,852,063
7 BaseVar 142,219,048
8 EconomicCapitalRatiobeforeLimitedLiability 1.82
9 EconomicCapitalRatio 2.90

Edgar->Model Mapping

Feature Distribution

Change over Time